COM:STOKETHERAPEUTICS
Stoke Therapeutics
- Stock
Last Close
11.27
22/11 21:00
Market Cap
691.12M
Beta: -
Volume Today
240.61K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -5.56M - | -12.52M 125.28% | -32.33M 158.17% | -52.24M 61.62% | -85.81M 64.24% | -101.07M 17.79% | -104.70M 3.59% | |
depreciation and amortization | 113K - | 214K 89.38% | 450K 110.28% | 888K 97.33% | 974K 9.68% | 1.55M 58.73% | 2.47M 59.70% | |
deferred income tax | 3K - | 172K 5,633.33% | 3.21M - | |||||
stock based compensation | 26K - | 240K 823.08% | 1.92M 700.83% | 5.77M 200.10% | 16.45M 185.19% | 22.85M 38.93% | 25.26M 10.51% | |
change in working capital | 31K - | 1.09M 3,425.81% | -1.10M 201.10% | 2.33M 310.41% | 46K 98.02% | 43.02M 93,428.26% | -3.21M 107.46% | |
accounts receivables | ||||||||
inventory | ||||||||
accounts payables | 891K - | 5.20M 483.95% | 2.90M 44.32% | 121K 95.82% | -3.21M 2,751.24% | |||
other working capital | 31K - | 1.09M 3,425.81% | -2.00M 282.62% | -2.88M 44.19% | -2.85M 0.94% | 42.90M 1,604.81% | 3.21M 92.52% | |
other non cash items | 4K - | 10K 150% | 3K 70% | 1.04M 34,500% | 1.26M 21.00% | 1.78M 41.56% | -886K 149.83% | |
net cash provided by operating activities | -5.38M - | -10.96M 103.64% | -31.05M 183.25% | -42.22M 35.96% | -66.91M 58.47% | -31.87M 52.37% | -81.07M 154.40% | |
investments in property plant and equipment | -113K - | -935K 727.43% | -1.64M 74.87% | -1.05M 35.78% | -1.20M 14.29% | -3.96M 230.17% | -1.62M 59.21% | |
acquisitions net | 1K - | 75.23M - | 45.34M 39.72% | |||||
purchases of investments | -87.23M - | -201.32M 130.80% | ||||||
sales maturities of investments | 12M - | 159.40M 1,228.33% | 107.56M 32.52% | |||||
other investing activites | 10K - | -75.23M - | -45.34M 39.72% | |||||
net cash used for investing activites | -113K - | -925K 718.58% | -1.63M 76.65% | -1.05M 35.74% | -76.43M 7,178.67% | -45.88M 39.97% | 105.95M 330.91% | |
debt repayment | ||||||||
common stock issued | 19K - | 151.91M 799,436.84% | 105.40M 30.62% | 1.29M 98.78% | 45.34M 3,425.97% | |||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 5.97M - | 115.62M 1,835.39% | -2.15M 101.86% | 2.71M 226.05% | -2K 100.07% | 1.06M 53,350% | 53.01M 4,877.18% | |
net cash used provided by financing activities | 5.97M - | 115.64M 1,835.70% | 149.76M 29.51% | 108.11M 27.81% | 1.28M 98.81% | 46.41M 3,514.41% | 53.01M 14.22% | |
effect of forex changes on cash | ||||||||
net change in cash | 477K - | 103.75M 21,650.52% | 117.07M 12.84% | 64.84M 44.62% | -142.05M 319.09% | -31.34M 77.94% | 77.89M 348.53% | |
cash at beginning of period | 1.38M - | 1.85M 34.67% | 105.60M 5,599.03% | 222.68M 110.86% | 287.51M 29.12% | 145.46M 49.41% | 114.13M 21.54% | |
cash at end of period | 1.85M - | 105.60M 5,599.03% | 222.68M 110.86% | 287.51M 29.12% | 145.46M 49.41% | 114.13M 21.54% | 192.01M 68.25% | |
operating cash flow | -5.38M - | -10.96M 103.64% | -31.05M 183.25% | -42.22M 35.96% | -66.91M 58.47% | -31.87M 52.37% | -81.07M 154.40% | |
capital expenditure | -113K - | -935K 727.43% | -1.64M 74.87% | -1.05M 35.78% | -1.20M 14.29% | -3.96M 230.17% | -1.62M 59.21% | |
free cash flow | -5.50M - | -11.90M 116.46% | -32.69M 174.73% | -43.27M 32.37% | -68.11M 57.40% | -35.83M 47.39% | -82.68M 130.78% |
All numbers in (except ratios and percentages)